Home › NCT06981156

Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)

Who can join

Ages 1 to 17 · All sexes

Inclusion Criteria:

* greater than or equal to 1 year old
* must be seen in the pediatric clinic
* Radiographic or histologic confirmation of a brain or spine tumor at the time of initial diagnosis
* Patient or parent/guardian must be able to understand the consent and be willing to sign a written informed consent document according to institutional guidelines.

Exclusion Criteria:

* none specified

About the study

This study aims to investigate a neurologic exam scale to provide an objective and more standard way to assess tumor response in pediatric patients with brain and spinal cord tumors.

What is being tested

• pNANO Assessment (diagnostic test)

Sponsor: University of Wisconsin, Madison · Participants: 252 · Started: May 13, 2025

Contact the study team

• Cancer Connect · Phone: 800-622-8922

Official record on ClinicalTrials.gov — NCT06981156

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.